Nanocage-incorporated engineered destabilized 3'UTR ARE of ERBB2 inhibits tumor growth and liver and lung metastasis in EGFR T790M Osimertinib-and trastuzumab-resistant and ERBB2-expressing non-small cell lung cancer (NSCLC) via the reduction of ERBB2 User montaukwhaler, in the non small cell lung cancer subreddit, 08 Apr 2024